Taiwan FDA registration d5f2d8f98f7fc37fa65c2bc817cd1a08

Yiren rapid pregnancy test reagent

TW: 伊人快速驗孕試劑

Taiwan·Risk Class 2·Longteng Biotechnology Co., Ltd. Xinshi Factory;; Laili Biomedical Technology Co., Ltd·Registered Dec 15, 2020 – Oct 26, 2028Active

Registration details

Analysis ID: d5f2d8f98f7fc37fa65c2bc817cd1a08

Company information

Manufacturer: Longteng Biotechnology Co., Ltd. Xinshi Factory;; Laili Biomedical Technology Co., Ltd
Manufacturer Country: Taiwan, Province of China
Authorized Representative: R&R MEDICAL CORPORATION LTD.

Product details

Intended Use: This product qualitatively detects human chorionic gonadotropins in human urine.
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A.1155 Human chorionic gonadotropin testing system
Import Information: 委託製造;; QMS/QSD;; 國產

Dates and status

Registration Date: Dec 15, 2020
Expiry Date: Oct 26, 2028

About this record

Access comprehensive regulatory information for Yiren rapid pregnancy test reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number d5f2d8f98f7fc37fa65c2bc817cd1a08 and manufactured by Longteng Biotechnology Co., Ltd. Xinshi Factory;; Laili Biomedical Technology Co., Ltd. The authorized representative in Taiwan is R&R MEDICAL CORPORATION LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.